Publication
Fibroblastic niches prime T cell alloimmunity through Delta-like Notch ligands
Journal Paper/Review - Mar 20, 2017
Chung Jooho, Onder Lucas, Yan Minhong, Reddy Pavan, Blazar Bruce R, Huang Alex Y, Brennan Todd V, Bishop D Keith, Ludewig Burkhard, Siebel Christian W, Radtke Freddy, Luther Sanjiv A, Chai Qian, Tran Ivy T, Ebens Christen L, Perkey Eric, Radojcic Vedran, Koch Ute, Scarpellino Leonardo, Tong Alexander, Allen Frederick, Wood Sherri, Feng Jiane, Friedman Ann, Granadier David, Maillard Ivan
Units
PubMed
Doi
Citation
Type
Journal
Publication Date
Issn Electronic
Pages
Brief description/objective
Alloimmune T cell responses induce graft-versus-host disease (GVHD), a serious complication of allogeneic bone marrow transplantation (allo-BMT). Although Notch signaling mediated by Delta-like 1/4 (DLL1/4) Notch ligands has emerged as a major regulator of GVHD pathogenesis, little is known about the timing of essential Notch signals and the cellular source of Notch ligands after allo-BMT. Here, we have shown that critical DLL1/4-mediated Notch signals are delivered to donor T cells during a short 48-hour window after transplantation in a mouse allo-BMT model. Stromal, but not hematopoietic, cells were the essential source of Notch ligands during in vivo priming of alloreactive T cells. GVHD could be prevented by selective inactivation of Dll1 and Dll4 in subsets of fibroblastic stromal cells that were derived from chemokine Ccl19-expressing host cells, including fibroblastic reticular cells and follicular dendritic cells. However, neither T cell recruitment into secondary lymphoid organs nor initial T cell activation was affected by Dll1/4 loss. Thus, we have uncovered a pathogenic function for fibroblastic stromal cells in alloimmune reactivity that can be dissociated from their homeostatic functions. Our results reveal what we believe to be a previously unrecognized Notch-mediated immunopathogenic role for stromal cell niches in secondary lymphoid organs after allo-BMT and define a framework of early cellular and molecular interactions that regulate T cell alloimmunity.